Originally developed as an anesthetic in the 1960s, ketamine has reemerged as one of modern psychiatry’s most promising tools for treatment-resistant depression, anxiety, and post-traumatic stress disorder. Its superpower lies in working with your brain's glutamate receptors to create antidepressant effects. What does the future of psychedelic-assisted mental health care hold? Could this once-stigmatized molecule represent the future of mental health care and healing the mind from within?

In this episode, we are joined by Dr. Mai Shimada, M.D., MBA, FAAEM. Dr. Shimada is a board-certified emergency medicine physician with over a decade of experience and is the founder and CEO of  ...